HUTCHMED (China) Limited

220.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:HCMHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 1.46%
Div yield —
ROE 1.46%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.49
PE TTM 144.6
TSR TTM —
Mkt cap £1.912B
ROIC (1.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
256p
16.34%
68.89%
Hold 8|9|8|7|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.25
2.35
2.40
2.57
17.51%
14.44%
9.03%
12.33%
Revenue$M
202.5
199.2
207.0
210.3
0.87%
(1.59%)
2.34%
3.75%
Peers (US$2.573B)
Cap (US$)
PE
40.09B
18.72x
Capital
TTM
5Y
10Y
Leveragex
0.685
(0.116)
(0.108)
EBIT/Intx
0.974
0.408
0.355
Own earn%
46.38
35.47
34.27
Sh yield%
26.13
47.23
45.67
Owners
Insiders/Inst%
8.07
51.19
Short interest%
1.46
SBC / revenue%
1.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
16–26
$1 testx
—
Incr. ROIC%
28